Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to -$3.4 million.

  • Cross Country Healthcare's Change in Accured Expenses fell 93573.57% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.5 million, marking a year-over-year increase of 6960.07%. This contributed to the annual value of -$29.8 million for FY2024, which is 7650.05% up from last year.
  • Cross Country Healthcare's Change in Accured Expenses amounted to -$3.4 million in Q3 2025, which was down 93573.57% from -$12.7 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Change in Accured Expenses ranged from a high of $63.0 million in Q1 2022 and a low of -$54.6 million during Q2 2023
  • Over the past 5 years, Cross Country Healthcare's median Change in Accured Expenses value was -$4.2 million (recorded in 2022), while the average stood at -$812684.2.
  • In the last 5 years, Cross Country Healthcare's Change in Accured Expenses soared by 158018.42% in 2021 and then plummeted by 93573.57% in 2025.
  • Cross Country Healthcare's Change in Accured Expenses (Quarter) stood at $46.6 million in 2021, then tumbled by 109.05% to -$4.2 million in 2022, then plummeted by 777.96% to -$37.0 million in 2023, then skyrocketed by 110.37% to $3.8 million in 2024, then crashed by 189.84% to -$3.4 million in 2025.
  • Its Change in Accured Expenses was -$3.4 million in Q3 2025, compared to -$12.7 million in Q2 2025 and -$9.2 million in Q1 2025.